Hidden Drug Resistant HIV to Emerge in the Era of Universal Treatment Access in Southeast Asia
Year: 2010
Type: article
Abstract: BACKGROUND: Universal access to first-line antiretroviral therapy (ART) for HIV infection is becoming more of a reality in most low and middle income countries in Asia. However, second-line therapies are relatively scarce. METHODS AND FINDINGS: We developed a mathematical model of an HIV epidemic in a Southeast Asian setting and used it to forecast the impact of treatment plans, without second-line options, on the potential degree of acquisition and transmission of drug resistant HIV strains. We show that after 10 years of universal treatment access, up to 20% of treatment-naïve individuals with HIV may have drug-resistant strains but it depends on the relative fitness of viral strains. CONCLUSIONS: If viral load testing of people on ART is carried out on a yearly basis and virological failure leads to effective second-line therapy, then transmitted drug resistance could be reduced by 80%. Greater efforts are required for minimizing first-line failure, to detect virological failure earlier, and to procure access to second-line therapies.
Source: PLoS ONE
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,382
Awards: G1134730793, Allocating scarce HIV/AIDS antiretroviral drugs in resource-constrained countries: using modelling to develop tools and analyse consequences of ethics and HIV-epidemiology, Using mathematical modelling to inform HIV/AIDS public health policy, IeDEA Asia-Pacific Research Collaboration
OpenAlex ID: W1983444422
